Oncology Institute (TOI) Share-based Compensation (2021 - 2026)

Oncology Institute has reported Share-based Compensation for 6 years, with the latest figure at $1.7 million in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation rose 15.64% year-over-year to $1.7 million; the trailing twelve-month figure through Mar 2026 stood at $4.8 million (down 43.93% YoY), and the FY2025 full-year result was $4.6 million, down 59.19% from the prior year.
• Share-based Compensation for Q1 2026 stood at $1.7 million, up from $1.3 million in the prior quarter.
• The five-year high for Share-based Compensation was $8.6 million in Q1 2022, with the low at $752000.0 in Q2 2025.
• Historically, Share-based Compensation has averaged $3.7 million across 5 years, with a median of $4.1 million in 2023.
• Annual changes were most pronounced in 2022 — Share-based Compensation jumped 20264.29% — and 2025, when it tumbled 77.8%.
• Oncology Institute's Share-based Compensation stood at $6.1 million in 2022, then tumbled by 32.8% to $4.1 million in 2023, then sank by 68.4% to $1.3 million in 2024, then increased by 2.17% to $1.3 million in 2025, then climbed by 28.02% to $1.7 million in 2026.
• The last three Share-based Compensation figures came in at $1.7 million (Q1 2026), $1.3 million (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.